# Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination

> **NCT06690502** · — · COMPLETED · sponsor: **PT Bio Farma** · enrollment: 1208 (actual)

## Conditions studied

- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06690502
- **Lead sponsor:** PT Bio Farma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-18
- **Primary completion:** 2024-06-03
- **Final completion:** 2024-06-07
- **Target enrollment:** 1208 (ACTUAL)
- **Last updated:** 2024-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06690502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06690502, "Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06690502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*